Lapachone

未知生产厂商

Lapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Lapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell.

技术标识符

化学式: C₁₅H₁₄O₃
CAS 编号: 4707-32-8
UNII ID: 6N4FA2QQ6A

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTATIC LIVER DISEASE, CONTAINING BETA-LAPACHONE AS ACTIVE INGREDIENT
EP 4023220 A4申请人: CUROME BIOSCIENCES CO LTD优先权: 2020
CN
EP
US
WO
7 件公开
Pharmaceutical compositions of -lapachone and -lapachone analogs with improved tumor targeting potential
US 7812051 B2申请人: ARQULE INC优先权: 2004
EP
US
WO
6 件公开
COMPOSITION COMPRISING DUNNIONE OR BETA-LAPACHONE AS ACTIVE INGREDIENT, FOR PREVENTING OR AMELIORATING FATIGUE, PAIN, COGNITIVE DECLINE AND HEMATOPOIETIC STEM CELL REDUCTION WHICH ARE SIDE EFFECTS RELATED TO ANTICANCER DRUG TREATMENT
EP 3449920 B1申请人: NADIANBIO LTD优先权: 2016
CN
EP
US
6 件公开
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
EP 3820433 A1申请人: NUCHIDO LTD优先权: 2018
CN
EP
US
WO
5 件公开
COMPOSITION FOR PREVENTING AND TREATING PANCREATITIS CONTAINING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT
EP 3284464 B1申请人: NADIANBIO LTD优先权: 2015
CN
EP
US
WO
4 件公开
USE OF BETA-LAPACHONE FOR PROTECTING AGAINST RADIATION INJURY
EP 1694322 A2申请人: ARQULE INC优先权: 2003
EP
US
WO
4 件公开
USE OF BETA-LAPACHONE FOR TREATING HEMATOLOGIC TUMORS
- EP 1722775 A1
  申请人: ARQULE INC优先权: 2004
  EP
  WO
  4 件公开
- WO 2005082357 A8
  申请人: ARQULE INC优先权: 2004
  WO
Method and composition for the treatment of cancer
US 2005171031 A1申请人: PARDEE ARTHUR B优先权: 2002
US
4 件公开
Lapachone compounds and methods of use thereof
- US 7902354 B2
  申请人: ARQULE INC优先权: 2007
  US
  4 件公开
- US 8067459 B2
  申请人: ASHWELL MARK优先权: 2008
  US
  2 件公开
ALBUMIN NANOPARTICLES, THE MAKING METHOD, AND USES THEREOF
US 2022118057 A1申请人: NOVAGENESIS THERAPEUTIX HK LTD优先权: 2019
CN
US
WO
3 件公开

药物

Lapachone

概览

专利

USE OF BETA-LAPACHONE FOR TREATING HEMATOLOGIC TUMORS

Lapachone compounds and methods of use thereof